by Truveta staff | Mar 11, 2024 | Research
Each year, approximately 900,000 patients in the US are affected by a pulmonary embolism (PE), a blood clot causing a blockage in one or more pulmonary arteries in the lungs. PE is a leading cause of in-hospital death in the US, and acute PE – a sudden blockage...
by Truveta staff | Feb 22, 2024 | Data, Technology
The National Academy of Medicine has estimated that less than half of all medical care in the US is supported by adequate evidence of effectiveness. The proliferation of treatment options in some disease states and the rising costs of many of those treatments have...
by Truveta staff | Feb 7, 2024 | Research
Truveta Research explored whether the rates of first-time anxiety diagnoses or first-time anxiety-related prescriptions were higher during the COVID-19 pandemic compared to the pre-pandemic era. We found that – with the brief exception of early 2021 – the rate of...
by Truveta staff | Jan 31, 2024 | Data
Clinical trials and registries have traditionally been the gold standard for high-quality healthcare data, offering complete longitudinal records across data domains in a clean, analysis-ready format. However, achieving this level of quality involves significant...
by Truveta staff | Jan 22, 2024 | News
Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S. Centers for Disease Control and Prevention (CDC) for privacy-preserving record linkage of patient-level real-world healthcare data....
